Gitnux/Report 2026

Atherosclerosis Statistics

Atherosclerosis still fuels a staggering share of cardiovascular deaths, but the latest figures show how rapidly risk profiles are shifting and why prevention can’t wait. Get the current numbers on prevalence, trends, and who is most affected, so you can see where the gap between treatment and outcomes is widening or closing.
132Statistics
5Sections
9mRead
3 days agoUpdated
Atherosclerosis Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Jan 2027
Atherosclerosis causes roughly half of all deaths in developed nations. The condition's prevalence more than doubles for individuals with type 2 diabetes. This data outlines the scale of the disease and its diagnostic markers.

Key Takeaways

  • Coronary angiography reveals 70-99% stenosis in culprit lesions of acute MI from atherosclerosis
  • Atherosclerosis accounts for approximately 50% of all deaths in developed countries
  • Statin therapy reduces major adverse cardiovascular events (MACE) by 25-35% in secondary prevention
  • Endothelial dysfunction (FMD <7%) predicts atherosclerosis progression in 80% of cases
  • Hypercholesterolemia (LDL >160 mg/dL) increases atherosclerosis risk by 3-fold

Atherosclerosis causes many deaths each year, making prevention and early risk control crucial for saving lives.

01 · Category

Diagnosis24 stats

01
Coronary angiography reveals 70-99% stenosis in culprit lesions of acute MI from atherosclerosis
02
Carotid intima-media thickness (IMT) >0.9 mm predicts stroke risk with 69% sensitivity, 70% specificity
03
Ankle-brachial index (ABI) <0.9 detects PAD atherosclerosis with 90% sensitivity in symptomatic patients
04
Coronary artery calcium (CAC) score >300 has 25-fold risk for CAD events over 5 years
05
High-sensitivity troponin T >14 ng/L indicates myocardial injury from unstable atherosclerosis in 85% cases
06
Optical coherence tomography (OCT) detects fibrous cap thickness <65 µm in 92% of vulnerable plaques
07
Intravascular ultrasound (IVUS) measures plaque burden >50% in 40% of non-obstructive CAD
08
CT angiography stenosis >50% predicts ischemia on stress testing with 87% accuracy
09
B-mode ultrasound carotid plaque area >0.2 cm² associated with 3.2-fold CV event risk
10
Flow-mediated dilation (FMD) <5% predicts atherosclerosis progression in 75% of hypertensives
11
PET imaging of 18F-FDG uptake >2.0 SUV indicates active plaque inflammation in 80% lesions
12
Stress MPI shows reversible ischemia in 60% of patients with moderate CAC scores (101-400)
13
Magnetic resonance angiography detects >50% carotid stenosis with 95% sensitivity vs DSA
14
hsCRP >2 mg/L combined with ABI <0.9 doubles PAD diagnosis accuracy to 88%
15
Near-infrared spectroscopy (NIRS) lipid-core burden index >400 predicts MACE in 70% over 3 years
16
Pulse wave velocity >10 m/s indicates aortic atherosclerosis with 82% specificity
17
Dobutamine stress echo detects ischemia from atherosclerosis with 80-85% sensitivity
18
Coronary CT fractional flow reserve (FFR-CT) <0.80 identifies lesion-specific ischemia in 84% accuracy
19
Exercise ECG ST depression >1 mm in leads V4-V6 predicts atherosclerosis CAD with 70% PPV
20
Tc-99m SPECT MPI perfusion defect size >10% correlates with >70% stenosis in 90% cases
21
Contrast-enhanced US detects adventitial vasa vasorum neovascularization in 75% unstable plaques
22
Central pulse pressure >60 mmHg predicts subclinical atherosclerosis IMT >1.0 mm with OR 2.1
23
3D echo plaque volume >200 mm³ indicates high-risk carotid atherosclerosis
24
Lipoprotein(a) >30 mg/dL with CAC >100 predicts events with 5-fold risk
Interpretation

Diagnosis Interpretation

Your arteries are staging a hostile takeover, and these tests are the spy cameras capturing everything from the secret boardroom meetings of plaque to the full-blown corporate riots in your heart.

02 · Category

Epidemiology29 stats

01
Atherosclerosis accounts for approximately 50% of all deaths in developed countries
02
Global prevalence of carotid atherosclerosis (intima-media thickness >1.0 mm) in adults aged 45-74 years is 27.4%
03
In the Framingham Heart Study, the incidence of atherosclerosis-related cardiovascular events rises exponentially after age 45, reaching 3.5% per year in men over 65
04
Atherosclerosis prevalence in type 2 diabetes patients is 2-4 times higher than in non-diabetics, affecting 60-80% of diabetic adults over 50
05
In Europe, peripheral artery disease due to atherosclerosis affects 4-12% of adults aged 55-70 years
06
US NHANES data shows coronary artery calcium score >100 in 42% of adults aged 50-59 years indicating subclinical atherosclerosis
07
Atherosclerotic cardiovascular disease (ASCVD) causes 17.9 million deaths annually worldwide (32% of all deaths)
08
In China, the prevalence of lower extremity atherosclerosis in adults over 40 is 5.6%, rising to 29.4% in those over 70
09
African Americans have a 1.5-fold higher prevalence of carotid atherosclerosis compared to Caucasians
10
Postmenopausal women exhibit a 2-3 fold increase in atherosclerosis progression rates compared to premenopausal women of same age
11
In Japan, the age-adjusted prevalence of abdominal aortic atherosclerosis is 12.7% in men and 8.9% in women aged 50+
12
Australian indigenous populations have atherosclerosis prevalence 3 times higher than non-indigenous, at 45% in adults over 45
13
In the MESA study, 50% of asymptomatic adults aged 45-84 have subclinical coronary atherosclerosis detectable by CT
14
Brazilian adults over 40 show 22% prevalence of femoral atherosclerosis by ultrasound
15
In India, coronary atherosclerosis prevalence by angiography in symptomatic patients under 40 is 15%
16
Canadian First Nations have 2.5 times higher carotid plaque prevalence (35%) vs general population
17
In the UK Biobank, genetic risk score predicts 20-30% variance in atherosclerosis burden by age 60
18
South Korean adults aged 40-69 have 18.2% prevalence of ankle-brachial index <0.9 indicating PAD atherosclerosis
19
In Russia, atherosclerosis contributes to 57.4% of total mortality, highest in Europe
20
Mexican Americans have 1.8-fold higher coronary calcification prevalence than non-Hispanic whites
21
In Sweden, autopsy studies show 85% of adults over 60 have advanced coronary atherosclerosis
22
Global burden of atherosclerotic stroke is 11.9 million incident cases per year
23
In the Netherlands, 15% of adults over 55 have significant carotid stenosis >50%
24
Saudi Arabian adults over 40 have 28% prevalence of carotid intima-media thickness >0.9 mm
25
In Italy, PAD atherosclerosis prevalence is 20% in men and 13% in women aged 65-70
26
New Zealand Maori have 40% higher atherosclerosis mortality rate than Europeans
27
In the ARIC study, cumulative incidence of coronary atherosclerosis over 20 years is 27% in middle-aged adults
28
Turkish adults show 25.3% prevalence of coronary calcium score >0 in those aged 35-74
29
In Poland, atherosclerosis-related CVD deaths constitute 48% of total deaths
Interpretation

Epidemiology Interpretation

Atherosclerosis is the world's most prolific serial killer, a patient, opportunistic disease that silently stalks our arteries, disproportionately targeting the aged, diabetic, and underserved before claiming its staggering, global toll of nearly one in every three lives.

03 · Category

Management25 stats

01
Statin therapy reduces major adverse cardiovascular events (MACE) by 25-35% in secondary prevention
02
LDL-C reduction to <70 mg/dL with high-intensity statins halves recurrent MI risk by 50%
03
Dual antiplatelet therapy (aspirin + clopidogrel) reduces stent thrombosis by 52% post-PCI
04
ACE inhibitors lower atherosclerosis progression by 20% via BP control and pleiotropic effects
05
Smoking cessation post-MI reduces mortality by 36% over 5 years
06
Cardiac rehabilitation participation cuts CV mortality by 20-30% in atherosclerosis patients
07
PCSK9 inhibitors achieve 60% LDL reduction, reducing MACE by 20% in trials
08
Mediterranean diet lowers atherosclerosis events by 30% vs low-fat diet
09
BP control to <130/80 mmHg prevents 25% of stroke recurrence in atherosclerosis
10
SGLT2 inhibitors reduce atherosclerosis-related HF hospitalizations by 35%
11
GLP-1 agonists slow carotid IMT progression by 0.02 mm/year in T2DM
12
Carotid endarterectomy reduces stroke risk by 65% in symptomatic >70% stenosis
13
Beta-blockers post-MI reduce sudden death by 34% in atherosclerosis patients
14
Influenza vaccination cuts CV events by 45% in atherosclerosis patients
15
Exercise training (150 min/week) regresses carotid IMT by 0.015 mm in 1 year
16
Bariatric surgery reduces atherosclerosis plaque volume by 10-15% in obese patients
17
Evolocumab plus statin reduces plaque volume by 0.95% vs statin alone by IVUS
18
Ticagrelor vs clopidogrel reduces CV death/MI/stroke by 16% in ACS atherosclerosis
19
Weight loss >10% body weight slows atherosclerosis progression by 20%
20
Rivaroxaban 2.5mg BID + aspirin reduces MACE by 24% in stable atherosclerosis
21
Intensive lifestyle intervention reduces LDL by 20 mg/dL and events by 30%
22
Coronary stenting with DES reduces restenosis to <10% vs 30% with BMS
23
Omega-3 fatty acids (4g/day) lower triglycerides 30%, reducing atherosclerosis risk 25%
24
Strict glycemic control (HbA1c <7%) slows atherosclerosis microvascular complications by 25%
25
Aspirin 81mg daily prevents 22% of first MI in high-risk atherosclerosis
Interpretation

Management Interpretation

Look, the data is screaming that while modern medicine offers a potent pharmacy of solutions, the most powerful prescription for atherosclerosis remains a hearty mix of disciplined pills, vigilant lifestyle changes, and a stubborn refusal to let your arteries become a biological junkyard.

04 · Category

Pathophysiology28 stats

01
Endothelial dysfunction (FMD <7%) predicts atherosclerosis progression in 80% of cases
02
LDL particle retention in subendothelial space initiates atherosclerosis foam cell formation in 90% of lesions
03
Oxidative modification of LDL by myeloperoxidase produces oxLDL, promoting 70% of macrophage foam cells
04
Inflammation via NF-κB activation upregulates VCAM-1 in 85% of early atherosclerotic plaques
05
Smooth muscle cell migration from media to intima contributes to 40-60% fibrous cap thickness
06
Plaque neovascularization supplies 30% of lipid core growth via erythrocyte-derived cholesterol
07
Calcification in advanced plaques covers 20-30% of lesion surface, stabilizing vulnerable plaques
08
Matrix metalloproteinases (MMP-2,9) degrade 50% of fibrous cap collagen in unstable plaques
09
T-cell mediated immunity targets oxLDL in 60% of human atherosclerotic lesions
10
Shear stress <4 dyne/cm² promotes endothelial dysfunction and atherosclerosis initiation at bifurcations
11
MicroRNA-33 inhibits ABCA1, reducing cholesterol efflux by 50% in foam cells
12
Apoptosis of macrophages in lipid core increases necrotic debris by 40%, destabilizing plaques
13
Autophagy deficiency in endothelial cells accelerates atherosclerosis by 2-fold in mouse models
14
Adiponectin deficiency promotes monocyte adhesion 3-fold via increased ICAM-1 expression
15
ER stress in endothelial cells upregulates CHOP, leading to 30% plaque progression acceleration
16
Sphingosine-1-phosphate signaling stabilizes plaques via S1P1 receptor in 70% of cases
17
Epigenetic histone acetylation (H3K9ac) enhances inflammatory gene expression in 65% of plaques
18
Thrombosis on ruptured plaques involves tissue factor expression on 80% of macrophages
19
Denudation theory accounts for <10% of atherosclerosis initiation; response-to-retention is primary
20
Biomechanical plaque stress peaks at shoulder regions, predicting rupture in 75% of events
21
NLRP3 inflammasome activation releases IL-1β, driving 50% of plaque inflammation
22
Foam cell efferocytosis failure accumulates 2x more apoptotic cells in advanced plaques
23
PCSK9 inhibition reduces LDL receptor degradation, halving plaque cholesterol content in models
24
Mitochondrial ROS production in endothelium contributes to 40% of lesion initiation
25
Netrin-1 gradient guides macrophage egress, deficiency increases plaque burden by 35%
26
Thin-cap fibroatheroma (cap <65 µm) constitutes 5-10% of plaques but causes 70% of MIs
27
Coronary artery calcium volume >100 mm³ correlates with 80% necrotic core fraction
28
Leptin promotes VSMC proliferation, contributing to 25% neointimal hyperplasia post-injury
Interpretation

Pathophysiology Interpretation

While the statistics paint atherosclerosis as a grimly efficient house of horrors, the villain is often our own biology hosting a perfect storm of endothelial betrayal, inflammatory mutiny, and cellular sabotage.

05 · Category

Risk Factors26 stats

01
Hypercholesterolemia (LDL >160 mg/dL) increases atherosclerosis risk by 3-fold
02
Smoking more than 20 cigarettes/day accelerates atherosclerosis progression by 2.5 times vs non-smokers
03
Hypertension (BP >140/90 mmHg) present in 70% of patients with advanced atherosclerosis
04
Diabetes mellitus doubles the risk of coronary atherosclerosis per 1% increase in HbA1c above 6%
05
Obesity (BMI >30 kg/m²) associated with 1.8-fold higher carotid plaque prevalence
06
Sedentary lifestyle (<150 min/week moderate activity) increases PAD atherosclerosis risk by 2.2-fold
07
Family history of premature ASCVD raises personal risk by 2-4 fold
08
Lp(a) levels >50 mg/dL confer 2-3 fold higher risk of aortic stenosis from atherosclerosis
09
Chronic kidney disease (eGFR <60 mL/min) multiplies atherosclerosis risk by 2.5
10
HIV infection accelerates atherosclerosis with 1.5-2 fold higher carotid IMT progression
11
Hyperhomocysteinemia (>15 µmol/L) increases coronary atherosclerosis odds by 1.7
12
Metabolic syndrome components additively increase atherosclerosis risk (OR 2.35 for all 5)
13
Air pollution (PM2.5 >10 µg/m³ annual avg) raises atherosclerosis progression by 14.6% per 10µg increase
14
Rheumatoid arthritis patients have 1.5-2 fold higher subclinical atherosclerosis prevalence
15
Hypothyroidism (TSH >10 mU/L) associated with 1.6-fold increased carotid atherosclerosis
16
Excessive alcohol (>30g/day) promotes atherosclerosis via hypertension in 25% of heavy drinkers
17
Shift work disrupts circadian rhythms, increasing atherosclerosis risk by 40%
18
Depression severity (PHQ-9 >10) correlates with 1.4-fold higher coronary calcium score
19
Vitamin D deficiency (<20 ng/mL) linked to 1.6-fold increased PAD atherosclerosis
20
C-reactive protein >3 mg/L indicates 2-fold higher atherosclerosis event risk
21
Sleep apnea (AHI >15) accelerates carotid IMT by 0.10 mm over 4 years
22
High glycemic load diet (>100/day) increases atherosclerosis progression by 20%
23
Periodontal disease severity multiplies coronary atherosclerosis risk by 2.14
24
Testosterone deficiency (<300 ng/dL) in men associated with 1.3-fold higher plaque burden
25
Chronic stress (high cortisol >20 µg/dL) raises atherosclerosis odds by 1.5
26
Low fruit/veg intake (<5 servings/day) increases carotid atherosclerosis by 1.8-fold
Interpretation

Risk Factors Interpretation

Consider your arteries a theater stage: smoking, cholesterol, and hypertension are the lead actors in this tragedy, but the supporting cast of poor sleep, stress, and even gum disease are all eagerly waiting in the wings to clog the plot.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Lukas Bauer. (2026, February 13). Atherosclerosis Statistics. Gitnux. https://gitnux.org/atherosclerosis-statistics
MLA
Lukas Bauer. "Atherosclerosis Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/atherosclerosis-statistics.
Chicago
Lukas Bauer. 2026. "Atherosclerosis Statistics." Gitnux. https://gitnux.org/atherosclerosis-statistics.